Abstract Submission

Please note: It is no longer possible to submit abstracts. If you want to submit a 'late breaker' please contact Wilco Keulen at Virology Education
wilco.keulen@vironet.com

General guidelines
Abstracts should contain the following four components (please bold the four section headings noted below within the text of your abstract submission).
Background: a concise statement of the issue under investigation or a hypothesis;
Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable); and
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
Please note that abstracts cannot be accepted if tables, graphs, grant acknowledgements or literature references are included.

Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstracts as scheduled.

Abstract submission
Authors can submit their abstracts electronically through a dedicated website. You will be redirected to the submission website. Please follow the step-by-step directions, which will enable you to upload the file containing your abstract from the computer system that you are using to access this website. To ensure your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories related to HIV Entry. You may indicate your preference according to the  topics listed below in the Remarks box.  Selection of the most appropriate category is important as it determines who will review your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. 
Topic 1: Mechanisms of viral entry
Topic 2: Inhibitors of viral entry
Topic 3: Resistance & pharmacology
Topic 4: Clinical trials with entry inhibitors
Topic 5: Diagnostic technologies & implications


Notification of abstract dispositions
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to submitting authors in the 2nd week of October. It is the responsibility of the corresponding/presenting author to inform all co-authors of the disposition status. Please notify the Conference Secretariat if you have not received notification by 13 October, 2008.

If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled.  Guidelines for preparing your oral and/or poster presentations will be sent together with notification of accepted abstract .

Abstract publication
Accepted abstracts will be published in the Abstract Book that will be distributed with the conference material. Presentations will be posted on the website. Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.